U.S. Software Stock News

As the U.S. stock market continues to edge higher, with the S&P 500 reaching new milestones and investor attention focused on Federal Reserve decisions and major tech earnings, dividend stocks remain an attractive option for those seeking steady income amidst market fluctuations. In this environment, a good dividend stock is characterized by its ability to offer consistent payouts and financial stability, providing investors with a reliable income stream even as broader economic conditions...

InMode (NASDAQ:INMD) has had a great run on the share market with its stock up by a significant 10% over the last week...

Cornerstone Bancorp (CNBP) closed out FY 2025 with fourth quarter total revenue of US$11.0 million and basic EPS of US$3.14, alongside net income of US$3.09 million that capped off a year of steady profitability. The company has seen quarterly revenue move from US$9.66 million in Q4 FY 2024 to US$11.0 million in Q4 FY 2025, while basic EPS over that same period went from US$3.02 to US$3.14, supported by a trailing twelve month net profit margin of 25.9% versus 25.7% a year earlier. Taken...

Capricor Therapeutics recently issued a regulatory update on its Biologics License Application for Deramiocel in Duchenne muscular dystrophy, confirming that the FDA has requested the full Phase 3 HOPE-3 clinical study report and supporting data, but no new clinical trials or patient data. The absence of a request for additional studies, combined with Capricor’s plan to submit the HOPE-3 report in February 2026, places the focus squarely on data interpretation and the potential for a new...

If you are wondering whether Alexander's current share price still offers value, it helps to step back and look at what the recent returns and fundamentals are really telling you. The stock most recently closed at US$239.55, with a 7 day return of 0.5% decline, a 30 day return of 9.8%, year to date return of 9.5%, and a 1 year return of 36.3%, which naturally raises questions about how much of this is already reflected in the price. These moves sit alongside a 3 year return of 27.7% and a 5...

If you are wondering whether Leidos Holdings at around US$187 per share still offers value after a strong run, this article will walk through what the current price might imply. The stock has delivered a 33.6% return over the past year and 96.3% over three years. More recently it has seen a 2.0% decline over 7 days and a 0.7% return over the last month, with a 2.0% return year to date. Investors have been paying close attention to Leidos because of its role as a major government and defense...

Zscaler (NasdaqGS:ZS) launched an AI Security Suite, targeting risks tied to enterprise AI adoption. The company also released its ThreatLabz 2026 AI Threat Report, finding critical vulnerabilities across all enterprise AI systems tested. The report indicates that most assessed AI environments could be compromised very quickly, highlighting gaps in current AI governance and security practices. Zscaler, best known for its cloud security platform, is pushing deeper into AI risk management as...

If you are wondering whether Denali Therapeutics' current share price lines up with its underlying worth, this review will walk through what the numbers are actually saying about value. The stock last closed at US$21.25, with returns of 21.2% over 7 days, 26.0% over 30 days, 30.6% year to date, but a 9.6% decline over 1 year, a 29.8% decline over 3 years, and a 70.8% decline over 5 years, which can change how investors think about both opportunity and risk. Recent attention on Denali...

Alaska Air Group (ALK) is back in focus after fourth quarter adjusted earnings per share came in ahead of expectations, alongside ongoing Hawaiian Airlines integration, cargo expansion plans, and a large Boeing aircraft order. See our latest analysis for Alaska Air Group. The earnings surprise and progress on integrating Hawaiian Airlines helped lift sentiment, with a 4% one day share price return contributing to an 8.82% 7 day gain and a 24.01% 90 day share price return, even though the 1...

If you are wondering whether Hubbell's current share price lines up with its underlying worth, you are not alone. This article is here to walk you through that question step by step. Hubbell shares last closed at US$484.14, with returns of 2.5% over 7 days, 6.4% over 30 days, 4.6% year to date, 18.7% over 1 year, 120.5% over 3 years, and 232.0% over 5 years, which naturally raises questions about what you are paying for today. Recent attention on Hubbell has been driven by ongoing investor...

Shareholders of Kenvue (NYSE:KVUE) are preparing to vote on a proposed sale of the company to Kimberly-Clark. The deal structure includes a mix of cash and Kimberly-Clark shares for Kenvue investors. Proxy advisory firms have recommended that shareholders back the transaction ahead of the vote. The proposal has drawn extra attention because litigation tied to Kenvue products is still ongoing. Kenvue, the consumer health company separated from Johnson & Johnson, sits at the intersection of...

If you are wondering whether Kinsale Capital Group's current share price reflects its true worth, you are not alone in asking that question. The stock recently closed at US$386.67, with returns of a 4.6% decline over 7 days, a 1.7% decline over 30 days, a 1.5% decline year to date, gains of 39.5% over 3 years and 108.3% over 5 years, while the last 12 months show a 12.4% decline. Recent attention around Kinsale Capital Group has focused on its share price performance and how investors are...

In recent days, BellRing Brands has come under pressure after a major bank flagged softer-than-expected trends in its Premier Protein line and a potentially difficult upcoming quarter, amid existing concerns around slower growth and profitability. An interesting angle for investors is that this caution coincides with Coca-Cola’s CEO highlighting strong consumer demand for protein-enriched beverages, underscoring a supportive backdrop for the category even as BellRing faces company-specific...

If you are wondering whether PayPal Holdings at around US$55.51 is a bargain or a value trap, you are not alone, and the numbers give us a lot to work with. The share price has moved 0.8% over the last week, while the 30 day return is a 7.4% decline and the 1 year return is a 36.9% decline, which will catch the eye of anyone thinking about growth potential or shifting risk perceptions. Recent attention on PayPal has centred on its position in digital payments, including ongoing market share...

Several law firms have announced investigations into Nutanix (NasdaqGS:NTNX) over potential securities law violations. The probes follow Nutanix's recent disclosure of a revenue shift and a downward revision to its full year revenue guidance. These developments come as Nutanix shares trade at $41.24, with recent returns under pressure. Nutanix, trading under NasdaqGS:NTNX, is back in focus after its updated revenue outlook and guidance cut triggered legal scrutiny from multiple firms. The...

Analysts are raising concerns that expiring Medicare telehealth reimbursement provisions could change how at-home virtual care visits are paid for, affecting Teladoc Health's (NYSE:TDOC) revenue mix. At the same time, BetterHelp, Teladoc's online therapy platform, is seeing a drop in monthly active users that analysts link to softer consumer sentiment. Together, these reimbursement questions and user trends are putting fresh attention on Teladoc's demand outlook across both medical and...

If you are wondering whether Costamare's current share price reflects its true worth, you are not alone. Many investors are asking the same question. Costamare's stock recently closed at US$16.33, with returns of 5.8% over 7 days, 3.9% over 30 days, 4.1% year to date, 98.0% over 1 year, 145.6% over 3 years and 241.2% over 5 years. Recent news around the container shipping and broader transportation sector has kept attention on companies like Costamare, as investors weigh supply chain trends,...

If you are wondering whether Charter Communications' recent share price slide has left the stock looking mispriced, you are not alone. The stock closed at US$182.99, with returns of a 0.7% decline over 7 days, an 11.7% decline over 30 days, a 12.6% decline year to date, a 49.9% decline over 1 year, a 52.4% decline over 3 years and a 70.3% decline over 5 years. Recent coverage has focused on Charter's position in the US cable and broadband market and how competitive pressures and changing...

Corvus Pharmaceuticals reported positive Phase 1 results for soquelitinib in moderate to severe atopic dermatitis, including patients who had limited response to prior therapies. The trial showed encouraging efficacy and safety data, prompting the company to outline plans for a larger Phase 2 study. Corvus expects to begin enrolling patients in the Phase 2 trial in early 2026. For investors tracking Corvus Pharmaceuticals, ticker NasdaqGM:CRVS, this update comes with the stock at $22.08 and...

Why Ziff Davis (ZD) is back on value investors' radar Recent discussion around Ziff Davis (ZD) centers on its seven acquisitions in 2025 across connectivity, cybersecurity, and MarTech, combined with active share repurchases and a focus on AI and AWS driven products. See our latest analysis for Ziff Davis. At a share price of $39.54, Ziff Davis has logged a 17.26% 90 day share price return and 16.33% year to date. Its 1 year total shareholder return of 28.12% and 3 year total shareholder...

WEX (NYSE:WEX) has launched a single fleet card that can be used for both traditional fuel purchases and public EV charging. The company has also entered a virtual card partnership with Nuvei to serve global travel merchants. For investors tracking NYSE:WEX, these product moves come with the stock trading at $156.7. Recent returns show a mixed picture, with the share price up 3.2% over the past week and 5.6% year to date, but with a 1-year return of a 13.7% decline and a 3-year return of a...

Northwest Bancshares (NWBI) has put up a solid finish to FY 2025, with Q4 total revenue of US$172.2 million and basic EPS of US$0.31. The company also reported trailing 12 month revenue of US$599.1 million and EPS of US$0.93, alongside earnings growth of 25.8% over the last year. Over recent periods the company has seen total revenue move from US$498.1 million on a trailing basis in Q4 2024 to US$599.1 million in Q4 2025, while trailing EPS has gone from US$0.79 to US$0.93 as net margin held...

If you are wondering whether Amprius Technologies at around US$11.58 is offering value or just excitement, you are not alone. The stock has posted a 3.7% return over the last 7 days, 40.0% over 30 days, 32.5% year to date, and 255.2% over the past year, which can change how investors think about both opportunity and risk. Recent attention has focused on Amprius Technologies as part of broader interest in battery and capital goods names, with investors watching how companies in this space...

First Busey Corporation (NasdaqGS:BUSE) has completed a multi year share repurchase program, retiring over 10% of its outstanding shares since 2015. The company announced the conclusion of the buyback alongside its latest annual earnings report. The end of the program marks a key capital allocation milestone that may influence future earnings per share calculations. First Busey, the holding company for Busey Bank, operates as a regional financial services provider with a focus on community...